Biopharmaceutical - Свежие новости [ Фото в новостях ] | |
Hoth Therapeutics approves purchase of $1m Bitcoin
Nasdaq-listed Hoth Therapeutics has announced plans to purchase Bitcoin as a treasury reserve asset. Hoth disclosed on Nov. 20 that its board of directors had approved the acquisition of $1 million worth of Bitcoin (BTC). дальше »
2024-11-20 18:03 | |
|
Hoth Therapeutics to buy up to $1 million worth of Bitcoin
Hoth Therapeutics, a publicly-traded biopharmaceutical company, has adopted Bitcoin (BTC) as a treasury asset. The clinical-stage biopharmaceutical company announced on Nov. 20 that its board of directors had approved adding BTC to its balance sheet. дальше »
2024-11-20 16:28 | |
|
|
Mirror Biologics, Inc. Announces Additional $20 Million Investment to Close Out $30 Million Series A Investment Round
Mirror Biologics, Inc., a clinical stage biopharmaceutical company today announced the completion of the final $20 million tranche of its $30 million Series A investment... дальше »
2022-10-12 17:52 | |
|
|
CureVac Announces Proposed U.S. IPO of Common Shares to Raise $245M
Coinspeaker CureVac Announces Proposed U. S. IPO of Common Shares to Raise $245MCureVac B. V. , a Dutch biopharmaceutical company, filed for an initial public offering on Friday, with plans to list on Nasdaq under the ticker "CVAC. дальше »
2020-8-11 19:15 | |
|
|
French Pharma Firm Transgene Utilizes Blockchain to Track Clinical Trials
In a recent press release, French biopharmaceutical firm Transgene announced its integration with blockchain supply chain traceability solution Hypertrust-X Chain for Clinical Trials for its individualized therapeutic vaccine against ovarian, head, and neck cancer to provide an immutable audit trail throughout the treatment process. дальше »
2020-7-12 17:00 | |
|
|
Why Pharma Stock ABIO Skyrocketed a Mind-Blowing 100%
By CCN. com: Biopharmaceutical company ARCA biopharma (NASDAQ: ABIO) led the stock market yesterday with a mind-blowing 98. 64% gain on the day. The ABIO stock price rocketed following an announcement that the company had a critical research paper published in JACC: Heart Failure, part of the Journal of American College of Cardiology. дальше »
2019-5-2 17:37 | |
|
|